Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats

Behavioural Brain Research

Volumn 268, Issue , 2014, Pages 169-176

  Gawel, Kinga ^a   Labuz, Krzysztof ^b   Jenda, Malgorzata ^a   Silberring, Jerzy ^c   Kotlinska, Jolanta H ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

^c AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Conditioned place preference; Donepezil; Morphine; Rivastigmine

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; DONEPEZIL; MECAMYLAMINE; MORPHINE; NICOTINIC RECEPTOR; RIVASTIGMINE; SCOPOLAMINE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; NARCOTIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; PIPERIDINE DERIVATIVE; SCOPOLAMINE BROMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG SEEKING BEHAVIOR; ENZYME INHIBITION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; TASK PERFORMANCE; TREATMENT OUTCOME; ANIMAL; CONDITIONING; DEPTH PERCEPTION; DRUG EFFECTS; MOTOR ACTIVITY; WISTAR RAT;

ANIMALS; CHOLINESTERASE INHIBITORS; CONDITIONING (PSYCHOLOGY); DRUG-SEEKING BEHAVIOR; INDANS; MALE; MECAMYLAMINE; MORPHINE; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; NARCOTICS; NICOTINIC ANTAGONISTS; PHENYLCARBAMATES; PIPERIDINES; RATS, WISTAR; SCOPOLAMINE HYDROBROMIDE; SPACE PERCEPTION;

EID: 84899894161     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.04.019     Document Type: Article

References (60)

1. Abdel-Aal R.A., Assi A.A., Kostandy B.B. Rivastigmine reverses aluminum-induced behavioral changes in rats. Eur J Pharmacol 2011, 659:169-176.
2. Aguilar M.A., Rodríguez-Arias M., Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 2009, 59:253-277.
3. Ahmadi S., Zarrindast M.R., Haeri-Rohani A., Rezayof A., Nouri M. Nicotine improves morphine-induced impairment of memory: possible involvement of N-methyl-d-aspartate receptors in the nucleus accumbens. Dev Neurobiol 2007, 67:1118-1127.
4. Ballard C.G., Greig N.H., Guillozet-Bongaarts A.L., Enz A., Darvesh S. Cholinesterases: roles in the brain during health and disease. Curr Alzheimer Res 2005, 2:307-318.
5. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward. Psychopharmacology 2000, 153:31-43.
6. Bechara A., van der Kooy D. Lesions of the tegmental pedunculopontine nucleus: effects on the locomotor activity induced by morphine and amphetamine. Pharmacol Biochem Behav 1992, 42:9-18.
7. Bozarth M.A., Wise R.A. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 1981, 28:551-555.
8. Bryant C.D., Zaki P.A., Carroll F.I., Evans C.J. Opioids and addiction: emerging pharmaceutical strategies for reducing reward and opponent processes. Clin Neurosci Res 2005, 5:103-115.
9. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends Neurosci 2000, 23:120-126.
10. Cerbai F., Giovannini M.G., Melani C., Enz A., Pepeu G. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine. Eur J Pharmacol 2007, 572:142-150.
11. Crespo J.A., Sturm K., Saria A., Zernig G. Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 2006, 26:6004-6010.
12. Dani J.A., Ji D., Zhou F.M. Synaptic plasticity and nicotine addiction. Neuron 2001, 31(3):349-352.
13. De La Garza R 2nd, Mahoney JJ 3rd, Culbertson C, Shoptaw S, Newton TF. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav 2008;89:200-8.
14. de Rover M., Lodder J.C., Kits K.S., Schoffelmeer A.N., Brussaard A.B. Cholinergic modulation of nucleus accumbens medium spiny neurons. Eur J Neurosci 2002, 16:2279-2290.
15. Devine D.P., Wise R.A. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 1994, 14:1978-1984.
16. Dooley M., Lamb H.M. Donepezil: a review of its use in Alzheimer's disease. Drugs Aging 2000, 16:199-226.
17. European Monitoring Centre for Drugs and Drug Addiction, European Drug Report 2013: Trends and developments. Luxembourg, 2013. doi:10.2810/88175.
18. Feng B., Xing J.H., Jia D., Liu S.B., Guo H.J., Li X.O., et al. Blocking α4β2 and α7 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice. Behav Brain Res 2011, 2200:100-105.
19. Giacobini E. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 2004, 50:433-440.
20. Goeders N.E., Lane J.D., Smith J.E. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav 1984, 20:451-455.
21. Goonawardena A.V., Robinson L., Hampson R.E., Riedel G. Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat. Learn Mem 2010, 17:502-511.
22. Grasing K., He S., Yang Y. Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats. Psychopharmacology 2008, 196:133-142.
23. Grasing K., Yang Y., He S. Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine. Behav Pharmacol 2011, 22:58-70.
24. Gronier B., Perry K.W., Rasmussen K. Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacology 2000, 147:347-355.
25. Hikida T., Kitabatake Y., Pastan I., Nakanishi S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci USA 2003, 100:6169-6173.
26. Hiranita T., Nawata Y., Sakimura K., Anggadiredja K., Yamamoto T. Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proc Natl Acad Sci USA 2006, 103:8523-8527.
27. Hoebel B.G., Avena N.M., Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol 2007, 7:617-627.
28. Hurd Y.L., Weiss F., Koob G., Ungerstedt U. The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci Lett 1990, 109:227-233.
29. Huston J.P., Silva M.A., Topic B., Müller C.P. What's conditioned in conditioned place preference. Trends Pharmacol Sci 2013, 34:162-166.
30. Ikemoto S., Wise R.A. Mapping of chemical trigger zones for reward. Neuropharmacology 2004, 47:190-201.
31. Kimmey BA, Rupprecht LE, Hayes MR, Schmidt HD. Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats. Addict Biol 2012. doi: 10.1111/adb.12014.
32. Liston D.R., Nielsen J.A., Villalobos A., Chapin D., Jones S.B., Hubbard S.T., et al. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Eur J Pharmacol 2004, 486:9-17.
33. Liu H., Lai M., Zhou X., Zhu H., Liu Y., Sun A., et al. Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats. Neuropharmacology 2012, 62:2515-2521.
34. Ma Y.Y., Chu N.N., Guo C.Y., Han J.S., Cui C.L. NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement. Exp Neurol 2007, 203:309-319.
35. Mark G.P., Shabani S., Dobbs L.K., Hansen S.T. Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 2011, 104:76-81.
36. Miller A.D., Blaha C.D. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat. Eur J Neurosci 2005, 21:1837-1846.
37. Miller A.D., Forster G.L., Yeomans J.S., Blaha C.D. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat. Neuroscience 2005, 136:531-538.
38. Myhrer T., Enger S., Aas P. Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents. Pharmacol Biochem Behav 2010, 95:338-343.
39. Nisell M., Nomikos G.G., Svensson T.H. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 1994, 75:348-352.
40. Ogura H., Kosasa T., Kuriya Y., Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find Exp Clin Pharmacol 2000, 22:609-613.
41. Olds M.E. Reinforcing effects of morphine in the nucleus accumbens. Brain Res 1982, 237:429-440.
42. Olmstead M.C., Franklin K.B. Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test. Neuroscience 1993, 57:411-418.
43. Olmstead M.C., Munn E.M., Franklin K.B., Wise R.A. Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci 1998, 18:5035-5044.
44. Power A.E., Vazdarjanova A., McGaugh J.L. Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 2003, 80:178-193.
45. Rada P., Mark G.P., Pothos E., Hoebel B.G. Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats. Neuropharmacology 1991, 30:1133-1136.
46. Rada P.V., Mark G.P., Taylor K.M., Hoebel B.G. Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacol Biochem Behav 1996, 53:809-816.
47. Rezayof A., Nazari-Serenjeh F., Zarrindast M.R., Sepehri H., Delphi L. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area. Eur J Pharmacol 2007, 562:92-102.
48. Salamone A., Zappettini S., Grilli M., Olivero G., Agostinho P., Tomé A.R., et al. Prolonged nicotine exposure down-regulates presynaptic NMDA receptors in dopaminergic terminals of the rat nucleus accumbens. Neuropharmacology 2014, 79:488-497.
49. Shams J., Sahraei H., Gholami A., Haeri-Rohani A., Alaf-Javadi M., Sepehri H., et al. Effects of ultra-low doses of nicotine on the expression of morphine-induced conditioned place preference in mice. Behav Pharmacol 2006, 17:629-635.
50. Smith J.E., Co C., Yin X., Sizemore G.M., Liguori A., Johnson W.E.3rd, et al. Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 2004, 27:841-850.
51. Takamatsu Y., Yamanishi Y., Hagino Y., Yamamoto H., Ikeda K. Differential effects of donepezil on methamphetamine and cocaine dependencies. Ann N Y Acad Sci 2006, 1074:418-426.
52. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
53. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998, 56:613-672.
54. Watabe-Uchida M., Zhu L., Ogawa S.K., Vamanrao A., Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012, 74:858-873.
55. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 2004, 5:483-494.
56. Yang G. Muscarinic receptors: a novel therapeutic target for drug addiction. Trends Pharmacol Sci 2002, 23:551.
57. Yeomans J.S., Mathur A., Tampakeras M. Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav Neurosci 1993, 107:1077-1087.
58. Zarrindast M.R., Fattahi Z., Rostami P., Rezayof A. Role of the cholinergic system in the rat basolateral amygdala on morphine-induced conditioned place preference. Pharmacol Biochem Behav 2005, 82:1-10.
59. Zarrindast M.R., Nouraei N., Khallilzadeh A., Askari E. Influence of acute and sub-chronic nicotine pretreatment on morphine state-dependent learning. Behav Brain Res 2006, 173:268-273.
60. Zhou W., Liu H., Zhang F., Tang S., Zhu H., Lai M., et al. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience 2007, 144:1209-1218.